Medtronic Bolsters Sinus Portfolio With $1.1Bn Intersect ENT Buyout

Medtronic announced plans to acquire Intersect ENT, adding its sinus implants to Medtronic's portfolio of devices used by surgeons in treating chronic rhinosinusitis.